SCNI - Scinai Immunotherapeutics Company Cash Volume

Official company branding of Scinai Immunotherapeutics Ltd. (SCNI)

Can Scinai Immunotherapeutics (SCNI) overcome low pricing power within the CDMO segment? Exclusive nanobody patents and powerful lobbying serve as a defense, creating barriers for competitors. Revenues are based on the development of biologics for infection therapy. The amount of cash on the balance sheet clearly demonstrates financial stability, while the value of 0.00 captures the level of the company's liquid reserve metric.

SCNI - BiondVax Pharmaceuticals Company Liquid Assets over the range 02/21/2024 - 11/21/2026

Analytical breakdowns and data insights for company Scinai Immunotherapeutics Ltd (SCNI)

- market capitalization statistics:
Fundamental company analysis:SCNI scinai.com
Brand item of Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics (SCNI) invests in the development of nanobodies for the therapy of chronic skin pathologies. This indicator measures the volume of liquid assets required to cover operating expenses until the commercialization of patents. The investor analyzes the burn rate to assess the risk of default or the necessity of a secondary offering. An optimal cash balance prevents capital stagnation. The company's cash history clearly demonstrates business resilience during the development period.

Competitors of Scinai Immunotherapeutics

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|KYTX - Company Cash Volume|TLSA (Tiziana Life Sciences PLC) - Company Cash on Hand|cabalettabio.com (CABA) - Company Cash Volume|Company Cash Funds Ventyx Biosciences|THTX (Theratechnologies) - Company Total Cash Amount|Company Cash on Hand AVTX (Avalo Therapeutics Inc.)|Company Cash Funds ELDN (Eledon)|Company Cash Volume AGEN (Agenus, Inc)|Company Liquid Assets climbbio.com (CLYM)|zurabio.com - Company Cash Volume|ATYR - Company Cash Volume|ADAG: Company Cash Volume|Ikena Oncology, Inc. (IMA) - Company Cash Volume|STTK (Shattuck Therapeutics) - Company Cash Volume|Company Cash Reserve equilliumbio.com EQ|Company Cash Volume CNTB|IMUX - Company Cash Reserve|Company Cash Funds Atara Biotherapeutics ATRA|Company Liquid Assets InflaRx N.V. (IFRX)|XFOR: Company Cash on Hand|adicetbio.com (ACET) - Company Cash on Hand|CELU: Company Cash Volume|Company Cash Reserve INmune Bio (INMB)|Company Cash Funds Barinthus Bio|Company Cash and Cash Equivalents KZR (Kezar Life Sciences, Inc)|Company Cash on Hand SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Company Cash and Cash Equivalents|Enlivex Therapeutics Ltd - Company Cash on Hand|Company Cash Balance QTTB|GOVX - Company Cash Funds|Company Cash Reserve Edesa|IBIO: Company Cash Volume|Company Cash Reserve Carisma Therapeutics Inc (CARM)|Company Cash Funds XTL Biopharmaceuticals, Ltd.|Company Cash Funds BOLT|Company Cash on Hand HCWB (HCW Biologics, Inc.)|Company Total Cash Amount APVO|AIM ImmunoTech - Company Cash on Hand|Company Cash Balance ADTX|GRI - Company Cash Funds|XRTX (XORTX Therapeutics Inc) - Company Cash and Cash Equivalents|HIND: Company Cash Volume|REVB (Revelation Bio) - Company Cash Funds|Company Cash Funds Indaptus|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD